銀皮症 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "銀皮症" in Japanese language version.

refsWebsite
Global rank Japanese rank
4th place
24th place
2nd place
6th place
218th place
712th place
low place
1,266th place
1st place
1st place
3,257th place
6,629th place
4,047th place
677th place
9,919th place
low place
low place
low place
low place
low place
294th place
1,499th place
low place
low place

ama-assn.org

jama.ama-assn.org

archotol.ama-assn.org

cdc.gov

atsdr.cdc.gov

csfacts.com

doi.org

  • Lansdown AB (2006). “Silver in health care: antimicrobial effects and safety in use”. Current Problems in Dermatology. Current Problems in Dermatology 33: 17–34. doi:10.1159/000093928. ISBN 3-8055-8121-1. PMID 16766878. 
  • Brandt D, Park B, Hoang M, Jacobe HT (August 2005). “Argyria secondary to ingestion of homemade silver solution”. Journal of the American Academy of Dermatology 53 (2 Suppl 1): S105–7. doi:10.1016/j.jaad.2004.09.026. PMID 16021155. 
  • Okan D, Woo K, Sibbald RG (June 2007). “So what if you are blue? Oral colloidal silver and argyria are out: safe dressings are in”. Advances in Skin & Wound Care 20 (6): 326–30. doi:10.1097/01.ASW.0000276415.91750.0f. PMID 17538258. "Colloidal silver suspensions are solutions of submicroscopic metallic silver particles suspended in a colloid base. These products deliver predominantly inactive metallic silver, not the antimicrobial ionized form." 
  • Geyer O, Rothkoff L, Lazar M (December 1989). “Clearing of corneal argyrosis by YAG laser”. The British Journal of Ophthalmology 73 (12): 1009–10. doi:10.1136/bjo.73.12.1009. PMC 1041957. PMID 2611183. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1041957/. 
  • Jacobs R (2006). “Argyria: my life story”. Clinics in dermatology 24 (1): 66–9; discussion 69. doi:10.1016/j.clindermatol.2005.09.001. PMID 16427508. 
  • Gaul LE, Staud AH (1935). “Seventy cases of generalized argyrosis following organic and colloidal silver medication, including a biospectrometric analysis of ten cases”. JAMA 104 (16): 1387–90. doi:10.1001/jama.1935.02760160011004. http://jama.ama-assn.org/cgi/content/summary/104/16/1387. 
  • Bryant BL (1940). "Argyria resulting from intranasal medication: a clinical and experimental study". Archives of Otolaryngology. 31 (1): 127–139. doi:10.1001/archotol.1940.00660010128013 (inactive 7 December 2009)。
  • Tien DC, Tseng KH, Liao CY, Tsung TT (October 2008). “Colloidal silver fabrication using the spark discharge system and its antimicrobial effect on Staphylococcus aureus”. Medical Engineering & Physics 30 (8): 948–52. doi:10.1016/j.medengphy.2007.10.007. PMID 18069039. 

internurse.com

msdmanuals.com

  • 色素増加”. メルクマニュアル. 2012年2月15日閲覧。

neurology.org

news.com.au

nibiohn.go.jp

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Lansdown AB (2006). “Silver in health care: antimicrobial effects and safety in use”. Current Problems in Dermatology. Current Problems in Dermatology 33: 17–34. doi:10.1159/000093928. ISBN 3-8055-8121-1. PMID 16766878. 
  • Brandt D, Park B, Hoang M, Jacobe HT (August 2005). “Argyria secondary to ingestion of homemade silver solution”. Journal of the American Academy of Dermatology 53 (2 Suppl 1): S105–7. doi:10.1016/j.jaad.2004.09.026. PMID 16021155. 
  • Okan D, Woo K, Sibbald RG (June 2007). “So what if you are blue? Oral colloidal silver and argyria are out: safe dressings are in”. Advances in Skin & Wound Care 20 (6): 326–30. doi:10.1097/01.ASW.0000276415.91750.0f. PMID 17538258. "Colloidal silver suspensions are solutions of submicroscopic metallic silver particles suspended in a colloid base. These products deliver predominantly inactive metallic silver, not the antimicrobial ionized form." 
  • Geyer O, Rothkoff L, Lazar M (December 1989). “Clearing of corneal argyrosis by YAG laser”. The British Journal of Ophthalmology 73 (12): 1009–10. doi:10.1136/bjo.73.12.1009. PMC 1041957. PMID 2611183. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1041957/. 
  • Jacobs R (2006). “Argyria: my life story”. Clinics in dermatology 24 (1): 66–9; discussion 69. doi:10.1016/j.clindermatol.2005.09.001. PMID 16427508. 
  • Mirsattari SM, Hammond RR, Sharpe MD, Leung FY, Young GB (April 2004). “Myoclonic status epilepticus following repeated oral ingestion of colloidal silver”. Neurology 62 (8): 1408–10. PMID 15111684. http://www.neurology.org/cgi/pmidlookup?view=long&pmid=15111684. 
  • “Over-the-counter drug products containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule”. Federal Register 64 (158): 44653–8. (August 1999). PMID 10558603. 
  • Tien DC, Tseng KH, Liao CY, Tsung TT (October 2008). “Colloidal silver fabrication using the spark discharge system and its antimicrobial effect on Staphylococcus aureus”. Medical Engineering & Physics 30 (8): 948–52. doi:10.1016/j.medengphy.2007.10.007. PMID 18069039. 
  • van Hasselt P, Gashe BA, Ahmad J (April 2004). “Colloidal silver as an antimicrobial agent: fact or fiction?”. Journal of Wound Care 13 (4): 154–5. PMID 15114827. http://www.internurse.com/cgi-bin/go.pl/library/article.cgi?uid=26606;article=JWC_13_4_154_155. 

ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

sotainstruments.com

web.archive.org